Physician profile
Ho Dzung
NPI 1891954293
$10,014.73
in general payments reported to CMS, 2019-2025
21 companies · $1,774 in 2025
The $1,774 reported for 2025 was more than what 80% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $879 · 2020: $677 · 2021: $1,799 · 2022: $1,648 · 2023: $2,027 · 2024: $1,210 · 2025: $1,774.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,011.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,190.86 | 2019-2025 | Proclaim, Octrode, Penta |
| Boston Scientific Corporation | $1,128.97 | 2019-2025 | General - Pain Management, Intracept, Wavewriter Alpha Prime 16 |
| Medtronic USA, INC. | $441.37 | 2019-2020 | |
| Spinefrontier, INC. | $410.36 | 2025 | Sijfuse, Facetfuse, Nanofuse |
| Spr Therapeutics, INC | $380.28 | 2021-2022 | |
| Stryker Corporation | $349.17 | 2022-2024 | Everest Spinal System, Mild Device Kit |
| Nevro Corp. | $245.59 | 2019-2023 | Senza |
| Medtronic, INC. | $207.01 | 2021-2022 | |
| Biotronik Nro, INC. | $149.23 | 2024-2025 | Prospera |
| Relievant Medsystems, INC. | $112.87 | 2021 | |
| Nalu Medical, INC. | $72.15 | 2022-2025 | Nalu Neurostimulation System |
| Forte Bio-Pharma LLC | $52.88 | 2020-2024 | Prolate, Nalocet |
| Collegium Pharmaceutical, INC. | $42.64 | 2025 | Belbuca |
| Si-Bone, INC. | $40.58 | 2022-2025 | |
| Vertos Medical, INC. | $37.91 | 2024 | Mild Device Kit |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $34.11 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pfizer INC. | $33.97 | 2019 | |
| Biodelivery Sciences International, INC. | $29.61 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $20.62 | 2025 | |
| Saluda Medical Americas, INC. | $17.66 | 2023 | Evoke Scs |
| Scilex Pharmaceuticals INC. | $16.89 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ho Dzung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.